Avicanna Announces Changes to its Board of Directors
(TSX:AVCN),(OTC US:AVCNF),(Other OTC:AVCNF),(Boerse Frankfurt – Freiverkehr:0NN),(Boerse Frankfurt – Freiverkehr:0NN.F), TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announces Mr. Paul Fornazzari's resignation from the Company's board of directors, and is pleased […]